Iambic Therapeutics, Inc. Common Stock

IAM

Valor de mercado US$ 1,13 bi

23,81 USD

+4,90

25,91%

No fechamento Atualizado 16 de out. 16:00 EDT

Pré-mercado

Após o fechamento do mercado

24,00

+0,19

0,8%

1 dia

25,91%

5 dias

47,43%

1 mês

25,91%

3 meses

25,91%

6 meses

25,91%

No acumulado do ano

25,91%

1 ano

25,91%

5 anos

25,91%

10 anos

25,91%

Sobre: Iambic Therapeutics Inc is a technology and clinical-stage life sciences company developing novel medicines using its proprietary molecular superintelligence platform.

Saúde Fabricantes de medicamentos — geral

Notícias

Positivo

Neutro

Negativo

Sentimento 3 meses

Positivo 0%

Neutro 100%

Negativo 0%

Neutro

Seeking Alpha

ontem

U.S. IPO Weekly Recap: Biotechs City Therapeutics And Iambic Headline The Week's Pricings

Three IPOs and two SPACs priced this week, and two SPACs submitted filings. No IPOs are currently scheduled for the week ahead as the year's next mega IPO potentially comes into view. Street research is expected to for one company in the week ahead, and four lock-up periods will be expiring.

Ver ranking de notícias

Gráficos de preços implementados com Lightweight Charts™

Iambic Therapeutics, Inc. Common Stock IAM Valor de mercado US$ 1,13 bi

Notícias

Iambic Therapeutics, Inc. Common Stock

IAM

Valor de mercado US$ 1,13 bi